Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Myriad Genetics, Inc. (MYGN) had Return on Tangible Equity of -0.06% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$195.90M |
|
$-0.10M |
|
$61.70M |
|
$134.20M |
|
$224.90M |
|
$-29.00M |
|
$-0.40M |
|
$-29.40M |
|
$-29.40M |
|
$-0.10M |
|
$-0.10M |
|
$-0.10M |
|
$-0.10M |
|
$-29.00M |
|
$-14.60M |
|
91.40M |
|
91.40M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$287.20M |
|
$114.00M |
|
$718.90M |
|
$1.01B |
|
$151.10M |
|
$59.30M |
|
$150.10M |
|
$301.20M |
|
$704.90M |
|
$161.10M |
|
$704.90M |
|
92.20M |
|
| Cash Flow Statement Financials | |
$-16.30M |
|
$-8.30M |
|
$13.60M |
|
$111.90M |
|
$101.00M |
|
$-10.90M |
|
$9.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.90 |
|
-- |
|
-- |
|
0.08 |
|
0.08 |
|
68.50% |
|
-14.80% |
|
-14.80% |
|
-- |
|
-15.01% |
|
-0.05% |
|
$-21.60M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
2.18 |
|
1.63 |
|
55.31 |
|
-0.01% |
|
|
Return on Tangible Equity |
-0.06% |
-0.01% |
|
-0.01% |
|
$7.65 |
|
$-0.24 |
|
$-0.18 |
|